Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Accelrys Transforms Lab-to-Commercialization Process with New Integrated Accelrys Process Management and Compliance Suite

Published: Thursday, September 20, 2012
Last Updated: Thursday, September 20, 2012
Bookmark and Share
Solution leverages industry-leading scientific informatics platform, delivering up to 25 percent productivity improvement, 50 percent decrease in cycle times and reduced compliance risks.

Accelrys, Inc., a leading provider of scientific innovation lifecycle management software, has announced the new integrated Accelrys Process Management and Compliance Suite of software products designed specifically to enhance product and process insight, facilitate collaboration and streamline product development from research through late-stage quality control and manufacturing. By improving the way businesses manage the scientific innovation lifecycle, the suite helps bring products to market faster and at a lower cost, while meeting critical quality and regulatory compliance objectives.

"Companies that rely on science to innovate continue to struggle with quickly and cost-effectively transforming good ideas into successful products," said Accelrys president and chief executive officer Max Carnecchia. "The unified approach to product development and process execution offered by the Accelrys Process Management and Compliance Suite provides a transformative path forward for organizations demanding new ways to accelerate innovation and retain competitive advantages."

The Accelrys Process Management and Compliance Suite directly integrates with systems critical to development and manufacturing processes such as laboratory information management systems (LIMS), enterprise resource planning (ERP), product lifecycle management (PLM) and manufacturing execution systems (MES). The ability to leverage existing applications and infrastructure, combined with the features of the Accelrys Process Management and Compliance Suite, offers organizations for the first time a single, unified source for harmonizing critical-path data and meeting the "right-first-time" needs of downstream manufacturing. The insights gained from the suite enhance reporting, decision making, knowledge management and operational excellence from lab to commercialization.

The Accelrys Process Management and Compliance Suite is the result of Accelrys' 2012 acquisition of VelQuest Corporation with its industry-leading paperless lab execution and data capture technology. The integrated suite comprises:

Accelrys Enterprise Platform
Accelrys Lab Execution System
Accelrys Electronic Lab Notebook (formerly Symyx Notebook by Accelrys)
Accelrys Electronic Batch Records

"For too long lab-to-market value chain processes have been managed by an outmoded combination of disconnected point solutions, paper notebooks and home-grown tools, creating a productivity gap that has slowed innovation," said Ken Rapp, managing director of Accelrys' analytical, development, quality and manufacturing solutions. "The Accelrys Process Management and Compliance Suite changes that paradigm. By combining the capabilities of an electronic lab notebook, lab execution system and an enterprise scientific informatics platform, Accelrys brings a holistic approach to solving common and costly operational challenges ranging from production quality issues and regulatory violations to shrinking margins."

Integration of the Accelrys Process Management and Compliance Suite with the Accelrys Enterprise Platform enables lifecycle aggregation, analytics and comprehensive reporting across the continuum from discovery to manufacturing, supporting Six Sigma and Quality by Design (QbD) programs and International Conference on Harmonization (ICH) initiatives in pharmacovigilance and risk management.

The Accelrys Process Management and Compliance Suite supports scientists working in early and mid-stage analytical, formulation and process/bioprocess development all the way through to stability, material and release testing during late-stage quality control and commercial production. By ensuring seamless technology transfer at the crucial research, development, pilot and manufacturing handoffs, the suite enables the rapid and accurate transfer of methods, recipes and procedures captured during early development into automated execution. As a result, customers have reported that they are experiencing up to 25 percent productivity improvement while cutting cycle times in half and reducing compliance risks.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Accelrys Announces 2012 US Tech Summit for IT Professionals
Fourth US Tech Summit for Accelrys customers will take place October 16-17 in New Jersey.
Sunday, October 21, 2012
Aquavit Pharmaceuticals Forms Alliance Partnership with Accelrys
Aquavit to utilize the Accelrys Enterprise Platform to develop advanced medical software for cutting-edge personalized medicine.
Sunday, October 14, 2012
Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia
Tailored academic license defines new informatics standard for multi-center collaborative research and Cloud-based data sharing
Saturday, June 02, 2012
Accelrys Acquires VelQuest Corporation for $35 Million in Cash
Extends reach downstream in the lab-to-market value chain with addition of industry-leading lab execution and data capture software
Monday, March 19, 2012
Accelrys Acquires VelQuest
Accelrys adds paperless lab execution systems to portfolio with acquisition of VelQuest Corporation.
Friday, January 06, 2012
Scientific News
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
New Autism Genes Are Revealed in Largest-Ever Study
Work draws more detailed picture of genetic risk, sheds light on sex differences in diagnosis.
Influenza A Viruses More Likely To Emerge In East Asia Than North America
Novel strains of influenza A are more likely to emerge in East Asia than in North America, according to a global analysis by the One Health Institute at the UC Davis School of Veterinary Medicine and EcoHealth Alliance.
Bone Risks Linked to Genetic Variants
A large-scale genomic study uncovered novel genetic variants and led researchers to an unexpected gene that affects bone density and fracture risk.
The Final Word on STAP
Researchers fail to replicate STAP study; computational analysis reveals genomic inconsistency.
Study Adds to Evidence That Viruses Are Alive
A new analysis supports the hypothesis that viruses are living entities that share a long evolutionary history with cells, researchers report.
CSI -- On The Metabolite's Trail
Bioinformaticians at the University of Jena make the most efficient search engine for molecular structures available online.
Potential Ovarian Cancer Biomarker Isolated
Researchers from North Carolina State University utilized a highly sensitive mass spectrometry analysis to identify and measure difficult-to-detect N-glycan biomarkers associated with ovarian cancers in stages I – IV.
Smartphone App to Monitor Serious Blood Disorder
A researcher from Florida Atlantic University has come up with a unique way to monitor sickle cell disease -- a serious blood disorder -- using a smart phone.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos